Private Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $4.04M | Sell |
53,939
-4,225
| -7% | -$325K | 0.95% | 29 |
|
|
2023
Q2 | $4.48M | Sell |
58,164
-9,811
| -14% | -$782K | 0.86% | 29 |
|
|
2023
Q1 | $5.64M | Sell |
67,975
-3,040
| -4% | -$252K | 0.93% | 29 |
|
|
2022
Q4 | $6.1M | Sell |
71,015
-6,169
| -8% | -$489K | 1.03% | 27 |
|
|
2022
Q3 | $4.76M | Buy |
77,184
+232
| +0.3% | +$14.6K | 0.84% | 32 |
|
|
2022
Q2 | $4.76M | Sell |
76,952
-8,043
| -9% | -$498K | 0.77% | 35 |
|
|
2022
Q1 | $5.05M | Sell |
84,995
-27,275
| -24% | -$1.74M | 0.69% | 39 |
|
|
2021
Q4 | $8.15M | Sell |
112,270
-2,185
| -2% | -$150K | 1% | 29 |
|
|
2021
Q3 | $8M | Sell |
114,455
-7,051
| -6% | -$495K | 1.09% | 28 |
|
|
2021
Q2 | $8.37M | Buy |
121,506
+2,276
| +2% | +$152K | 1.11% | 26 |
|
|
2021
Q1 | $7.71M | Buy |
119,230
+14,149
| +13% | +$912K | 1.08% | 29 |
|
|
2020
Q4 | $6.12M | Buy |
105,081
+9,487
| +10% | +$572K | 0.92% | 33 |
|
|
2020
Q3 | $6.04M | Buy |
95,594
+5,005
| +6% | +$347K | 1.01% | 30 |
|
|
2020
Q2 | $6.97M | Sell |
90,589
-11,369
| -11% | -$871K | 1.24% | 27 |
|
|
2020
Q1 | $7.62M | Sell |
101,958
-11,775
| -10% | -$814K | 1.6% | 22 |
|
|
2019
Q4 | $7.39M | Buy |
113,733
+4,536
| +4% | +$295K | 1.2% | 25 |
|
|
2019
Q3 | $6.92M | Buy |
109,197
+2,070
| +2% | +$135K | 1.2% | 27 |
|
|
2019
Q2 | $7.24M | Sell |
107,127
-2,530
| -2% | -$166K | 1.23% | 25 |
|
|
2019
Q1 | $7.13M | Sell |
109,657
-2,580
| -2% | -$171K | 1.27% | 27 |
|
|
2018
Q4 | $7.02M | Sell |
112,237
-12,463
| -10% | -$871K | 1.36% | 23 |
|
|
2018
Q3 | $9.63M | Buy |
124,700
+2,635
| +2% | +$199K | 1.52% | 20 |
|
|
2018
Q2 | $8.65M | Sell |
122,065
-460
| -0.4% | -$32.5K | 1.4% | 22 |
|
|
2018
Q1 | $9.24M | Sell |
122,525
-8,754
| -7% | -$696K | 1.58% | 23 |
|
|
2017
Q4 | $9.4M | Sell |
131,279
-11,126
| -8% | -$845K | 1.5% | 24 |
|
|
2017
Q3 | $11.5M | Buy |
142,405
+23,555
| +20% | +$1.8M | 1.86% | 18 |
|
|
2017
Q2 | $8.41M | Buy |
118,850
+3,440
| +3% | +$229K | 1.36% | 27 |
|
|
2017
Q1 | $7.84M | Buy |
115,410
+4,582
| +4% | +$322K | 1.28% | 30 |
|
|
2016
Q4 | $7.94M | Buy |
110,828
+1,100
| +1% | +$81.8K | 1.32% | 27 |
|
|
2016
Q3 | $8.68M | Buy |
109,728
+6,887
| +7% | +$559K | 1.45% | 25 |
|
|
2016
Q2 | $8.58M | Buy |
102,841
+1,457
| +1% | +$129K | 1.51% | 22 |
|
|
2016
Q1 | $9.31M | Sell |
101,384
-5,520
| -5% | -$498K | 1.69% | 21 |
|
|
2015
Q4 | $10.8M | Buy |
106,904
+35
| +0% | +$3.64K | 1.96% | 18 |
|
|
2015
Q3 | $10.5M | Buy |
106,869
+1,617
| +2% | +$180K | 1.96% | 16 |
|
|
2015
Q2 | $12.3M | Sell |
105,252
-1,157
| -1% | -$126K | 2.07% | 16 |
|
|
2015
Q1 | $10.4M | Sell |
106,409
-19,025
| -15% | -$1.93M | 1.7% | 20 |
|
|
2014
Q4 | $11.8M | Buy |
125,434
+1,580
| +1% | +$163K | 1.88% | 17 |
|
|
2014
Q3 | $13.2M | Sell |
123,854
-3,345
| -3% | -$328K | 2.11% | 12 |
|
|
2014
Q2 | $10.5M | Buy |
127,199
+4,225
| +3% | +$329K | 1.7% | 16 |
|
|
2014
Q1 | $8.71M | Sell |
122,974
-600
| -0.5% | -$47.1K | 1.47% | 23 |
|
|
2013
Q4 | $9.28M | Buy |
123,574
+1,935
| +2% | +$135K | 1.6% | 18 |
|
|
2013
Q3 | $7.65M | Buy |
121,639
+1,450
| +1% | +$86.7K | 1.47% | 20 |
|
|
2013
Q2 | $6.16M | Buy |
+120,189
| New | +$6.26M | 1.18% | 28 |
|
Other funds holding GILD
Private Asset Management's GILD Position: Q3 2023 in Review
Private Asset Management reduced its Gilead Sciences (GILD) stake by 7.3% in Q3 2023, selling an estimated $325K and leaving 53,939 shares worth $4.04M. The position accounts for 0.95% of the portfolio, ranked #29.
Private Asset Management first reported a position in GILD in Q2 2013 and has held it in 42 quarters since. The position peaked at $13.2M in Q3 2014. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.
- Private Asset Management held 53,939 shares of Gilead Sciences worth $4.04M as of Q3 2023.
- Private Asset Management sold 4,225 Gilead Sciences shares in Q3 2023, an estimated $325K.
- Gilead Sciences made up 0.95% of Private Asset Management's portfolio in Q3 2023, its #29 holding.
- Private Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 42 quarters since.
- Private Asset Management's Gilead Sciences position peaked at $13.2M in Q3 2014.
- 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.
Based on Private Asset Management's 13F filing for Q3 2023, filed 20 Oct 2023.